TELO · Telomir Pharmaceuticals, Inc. · Documents
$1.03
+0.02 (+1.49%)
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the issuance date of this Report.”View the 10-Q filed Aug 13, 2026
Market Cap
$69.46M
Shares
68.77M
Volume · Oct 21
23.28K
Avg daily vol (3M)
92.59K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | — | |
| 8-K | — | 2025-03-19 | — | |
| 8-K | — | 2025-02-25 | — | |
| 8-K | — | 2025-02-20 | — | |
| 8-K | — | 2025-02-18 | — | |
| 10-K | — | 2025-02-04 | 2024-12-31 | |
| 8-K | — | 2025-01-28 | — | |
| 8-K | — | 2025-01-07 | — | |
| 8-K | — | 2024-12-23 | — | |
| 8-K | — | 2024-12-20 | 2024-12-16 | |
| 8-K | — | 2024-12-11 | 2024-12-09 | |
| 8-K | — | 2024-12-02 | — | |
| 8-K | — | 2024-11-21 | 2024-11-18 | |
| 8-K | — | 2024-11-20 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-09-27 | — | |
| 8-K | — | 2024-09-03 | — | |
| 10-Q | — | 2024-08-13 | 2024-06-30 | |
| 8-K | — | 2024-06-24 | 2024-06-18 | |
| 10-Q | — | 2024-05-13 | 2024-03-31 | |
| 8-K | — | 2024-04-15 | — | |
| 8-K | — | 2024-04-12 | — | |
| 10-K | — | 2024-03-29 | 2023-12-31 | |
| 8-K | — | 2024-02-13 | 2024-02-08 |
Showing 51–75 of 75 filings